Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer

Breast Cancer Research and Treatment

Volumn 92, Issue 2, 2005, Pages 133-140

  Wagner, Kerstin ^a   Hemminki, Kari ^a,b   Israelsson, Elisabeth ^b   Grzybowska, Ewa ^c   Söderberg, Magnus ^d   Pamula, Jolanta ^c   Pekala, Wioletta ^c   Zientek, Helena ^c   Mielzynska, Danuta ^e   Siwinska, Ewa ^e   Försti, Asta ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e INSTITUTE OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH   (Poland)

Author keywords

Breast cancer; Case control study; IGF 1; IGFBP3; Polymorphism

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILIAL CANCER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE;

EID: 21644469613     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-2417-x     Document Type: Article

References (38)

1. P Lichtenstein NV Holm PK Verkasalo A Iliadou J Kaprio M Koskenvuo E Pukkala A Skytthe K Hemminki 2000 Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 78 85
2. K Hemminki C Granstrom 2003 Familial breast cancer: scope for more susceptibility genes Breast Cancer Res Treat 82 17 22
3. J Peto N Collins R Barfoot S Seal W Warren N Rahman DF Easton C Evans J Deacon MR Stratton 1999 of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 91 943 949
4. AC Antoniou PD Pharoah G McMullan NE Day BA Ponder D Easton 2001 Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study Genet Epidemiol 21 1 18
5. MM de Jong IM Nolte GJ te Meerman WT van der Graaf JC Oosterwijk JH Kleibeuker M Schaapveld EG de Vries 2002 Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J Med Genet 39 225 242
6. DL Kleinberg 1998 Role of IGF-I in normal mammary development Breast Cancer Res Treat 47 201 208
7. C Laban SA Bustin PJ Jenkins 2003 The GH-IGF-I axis and breast cancer Trends Endocrinol Metab 14 28 34
8. L Jerome L Shiry B Leyland-Jones 2003 Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions Endocr Relat Cancer 10 561 578
9. MN Pollak ES Schernhammer SE Hankinson 2004 Insulin-like growth factors and neoplasia Nat Rev Cancer 4 505 518
10. VS Sivaraman H Wang GJ Nuovo CC Malbon 1997 Hyperexpression of mitogen-activated protein kinase in human breast cancer J Clin Invest 99 1478 1483
11. H Yu T Rohan 2000 Role of the insulin-like growth factor family in cancer development and progression J Natl Cancer Inst 92 1472 1489
12. R Shi H Yu J McLarty J Glass 2004 IGF-I and breast cancer: a meta-analysis Int J Cancer 111 418 423
13. AG Renehan M Zwahlen C Minder ST O'Dwyer SM Shalet M Egger 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 1346 1353
14. M Harrela H Koistinen J Kaprio M Lehtovirta J Tuomilehto J Eriksson L Toivanen M Koskenvuo P Leinonen R Koistinen M Seppala 1996 Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3 J Clin Invest 98 2612 2615
15. TL McCarthy C Ji H Shu S Casinghino K Crothers P Rotwein M Centrella 1997 17beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures J Biol Chem 272 18132 18139
16. H Yu BD Li M Smith R Shi HJ Berkel I Kato 2001 Polymorphic CA repeats in the IGF-I gene and breast cancer Breast Cancer Res Treat 70 117 122
17. SA Missmer CA Haiman DJ Hunter WC Willett GA Colditz FE Speizer MN Pollak SE Hankinson 2002 A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer Int J Cancer 100 332 336
18. H Jernstrom W Chu D Vesprini Y Tao N Majeed C Deal M Pollak SA Narod 2001 Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk Mol Genet Metab 72 144 154
19. CJ Rosen ES Kurland D Vereault RA Adler PJ Rackoff WY Craig S Witte J Rogers JP Bilezikian 1998 between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density J Clin Endocrinol Metab 83 2286 2290
20. C Deal J Ma F Wilkin J Paquette F Rozen B Ge T Hudson M Stampfer M Pollak 2001 Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators J Clin Endocrinol Metab 86 1274 1280
21. ES Schernhammer SE Hankinson DJ Hunter MJ Blouin MN Pollak 2003 Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk Int J Cancer 107 60 64
22. Z Ren Q Cai XO Shu H Cai C Li H Yu YT Gao W Zheng 2004 Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women Cancer Epidemiol Biomarkers Prev 13 1290 1295
23. K Holli R Valavaara G Blanco V Kataja P Hietanen M Flander E Pukkala H Joensuu 2000 Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer. Finnish breast cancer group J Clin Oncol 18 3487 3494
24. Q Jin K Hemminki E Grzybowska R Klaes M Säderberg H Zientek J Rogozinska-Szczepka B Utracka-Hutka J Pamula W Pekala A Försti 2004 Polymorphisms and haplotype structures in genes for transforming growth factor 1 and its receptors in familial and unselected breast cancers Int J Cancer 112 94 99
25. A Forsti Q Jin E Grzybowska M Soderberg H Zientek M Sieminska J Rogozinska-Szczepka E Chmielik B Utracka-Hutka K Hemminki 2002 Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer Carcinogenesis 23 1315 1320
26. P Vaittinen K Hemminki 2000 Risk factors and age-incidence relationships for contralateral breast cancer Int J Cancer 88 998 1002
27. S Garte L Gaspari AK Alexandrie C Ambrosone H Autrup JL Autrup H Baranova L Bathum S Benhamou P Boffetta C Bouchardy K Breskvar J Brockmoller I Cascorbi ML Clapper C Coutelle A Daly M Dell'Omo V Dolzan CM Dresler A Fryer A Haugen DW Hein A Hildesheim A Hirvonen LL Hsieh M Ingelman-Sundberg I Kalina D Kang M Kihara C Kiyohara P Kremers P Lazarus L Le Marchand MC Lechner EM van Lieshout S London JJ Manni CM Maugard S Morita V Nazar-Stewart K Noda Y Oda FF Parl R Pastorelli I Persson WH Peters A Rannug T Rebbeck A Risch L Roelandt M Romkes D Ryberg J Salagovic B Schoket J Seidegard PG Shields E Sim D Sinnet RC Strange I Stucker H Sugimura J To-Figueras P Vineis MC Yu E Taioli 2001 Metabolic gene polymorphism frequencies in control populations Cancer Epidemiol Biomarkers Prev 10 1239 1248
28. K Wagner K Hemminki E Grzybowska R Klaes D Butkiewicz J Pamula W Pekala H Zientek D Mielzynska E Siwinska A Forsti 2004 The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer Carcinogenesis 25 2473 2478
29. K DeLellis S Ingles L Kolonel R McKean-Cowdin B Henderson F Stanczyk NM Probst-Hensch 2003 IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort Br J Cancer 88 277 282
30. ML Slattery W Samowitz K Curtin KN Ma M Hoffman B Caan S Neuhausen 2004 Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer Cancer Epidemiol Biomarkers Prev 13 1206 1214
31. E Giovannucci CA Haiman EA Platz SE Hankinson MN Pollak DJ Hunter 2002 Dinucleotide repeat in the insulin-like growth factor-I gene is not related to risk of colorectal adenoma Cancer Epidemiol Biomarkers Prev 11 1509 1510
32. RS Houlston J Peto 2003 The future of association studies of common cancers Hum Genet 112 434 435
33. AC Antoniou DF Easton 2003 Polygenic inheritance of breast cancer: Implications for design of association studies Genet Epidemiol 25 190 202
34. DB Goldstein JN Hirschhorn 2004 In genetic control of disease, does 'race' matter? Nat Genet 36 1243 1244
35. L Li MS Cicek G Casey JS Witte 2004 No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer Cancer Epidemiol Biomarkers Prev 13 497 498
36. AJ Sigurdson M Hauptmann N Chatterjee BH Alexander MM Doody JL Rutter JP Struewing 2004 Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair BRCA1 interacting and growth factor genes BMC Cancer 4 9
37. L Wang T Habuchi N Tsuchiya K Mitsumori C Ohyama K Sato H Kinoshita T Kamoto A Nakamura O Ogawa T Kato 2003 Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer Cancer Res 63 4407 4411
38. K Hemminki A Forsti J Lorenzo Bermejo 2005 Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events J Carcinog 4 2